Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Alarcan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Transplantation|April 20, 2022
Perfusate Metabolomics Content and Expression of Tubular Transporters During Human Kidney Graft Preservation by Hypothermic Machine PerfusionQuentin Faucher, Hugo Alarcan, François-Ludovic Sauvage, et al.
Journal of Neuropathology and Experimental Neurology|June 29, 2025
Identification of disease-associated molecular signatures in the Prp-TDP-43A315T mouse model of ALS: Toward preclinical biomarker developmentYara Al Ojaimi, Samira Osman, Hugo Alarcan, et al.
British Journal of Clinical Pharmacology|September 15, 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiencyMaud Maillard, Manon Launay, Bernard Royer, et al.
Plos One|August 4, 2025
scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathyYara Al Ojaimi, Rudolf Hergesheimer, Anna A Chami, et al.
Molecular Neurobiology|May 28, 2026
Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS CohortHugo Alarcan, Charlotte Veyrat-Durebex, Pierre-François Pradat, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Fundamental & Clinical Pharmacology|January 6, 2026
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in PharmacogeneticsNicolas Picard, Estelle Ayme-Dietrich, Sylvie Quaranta, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Transplantation|April 20, 2022
Perfusate Metabolomics Content and Expression of Tubular Transporters During Human Kidney Graft Preservation by Hypothermic Machine PerfusionQuentin Faucher, Hugo Alarcan, François-Ludovic Sauvage, et al.
Journal of Neuropathology and Experimental Neurology|June 29, 2025
Identification of disease-associated molecular signatures in the Prp-TDP-43A315T mouse model of ALS: Toward preclinical biomarker developmentYara Al Ojaimi, Samira Osman, Hugo Alarcan, et al.
British Journal of Clinical Pharmacology|September 15, 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiencyMaud Maillard, Manon Launay, Bernard Royer, et al.
Plos One|August 4, 2025
scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathyYara Al Ojaimi, Rudolf Hergesheimer, Anna A Chami, et al.
Molecular Neurobiology|May 28, 2026
Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS CohortHugo Alarcan, Charlotte Veyrat-Durebex, Pierre-François Pradat, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Fundamental & Clinical Pharmacology|January 6, 2026
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in PharmacogeneticsNicolas Picard, Estelle Ayme-Dietrich, Sylvie Quaranta, et al.
Pageof 3